DANSPOT: A Multicenter Stepped‐Wedge Cluster‐Randomized Trial of the Reclassification of Acute Myocardial Infarction: Rationale and Study Design
Journal of the American Heart Association · 07.05.2024 · 13 (9)
DOI: 10.1161/jaha.123.033493 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 07.05.2024. Verfasst von Nina Strandkjær und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine Copenhagen University Hospital-Herlev and Gentofte Herlev Denmark. Hauptthemen laut MEDLINE: Biomarkers, Myocardial Infarction, Troponin. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Cardiac troponins are the preferred biomarkers for the diagnosis of acute myocardial infarction. Although sex‐specific 99th percentile thresholds of troponins are recommended in international guidelines, the clinical effect of their use is poorly investigated. The DANSPOT Study (The Danish Study of Sex‐ and Population‐Specific 99th percentile upper reference limits of Troponin) aims to evaluate the clinical effect of a prospective implementation of population‐ and sex‐specific diagnostic thresholds of troponins into clinical practice.
Methods
This study is a nationwide, multicenter, stepped‐wedge cluster‐randomized trial of the implementation of population‐ and sex‐specific thresholds of troponins in 22 of 23 clinical centers in Denmark. We established sex‐specific thresholds for 5 different troponin assays based on troponin levels in a healthy Danish reference population. Centers will sequentially cross over from current uniform manufacturer‐derived thresholds to the new population‐ and sex‐specific thresholds. The primary cohort is defined as patients with symptoms suggestive of acute coronary syndrome having at least 1 troponin measurement performed within 24 hours of arrival with a peak troponin value between the current uniform threshold and the new sex‐specific female and male thresholds. The study will compare the occurrence of the primary outcome, defined as a composite of nonfatal myocardial infarction, unplanned revascularization, and all‐cause mortality within 1 year, separately for men and women before and after the implementation of the new sex‐specific thresholds.
Conclusions
The DANSPOT Study is expected to show the clinical effects on diagnostics, treatment, and clinical outcomes in patients with myocardial infarction of implementing sex‐specific diagnostic thresholds for troponin based on a national Danish reference population. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05336435.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine Copenhagen University Hospital-Herlev and Gentofte Herlev Denmark.
- Department of Cardiology Copenhagen University Hospital-Herlev and Gentofte Herlev Denmark.
- Department of Clinical Medicine University of Copenhagen Denmark.
- Department of Public Health University of Copenhagen Denmark.
- Department of Cardiology Zealand University Hospital Roskilde Denmark.
- Department of Cardiology Copenhagen University Hospital-Rigshospitalet Copenhagen Denmark.
ORCID-Profile: Nina Strandkjær, Rasmus Bo Hasselbalch, Jonas Kristensen, Thilde Olivia Kock, Theis Lange, Matias Greve Lindholm, Niels Eske Bruun, Christian Juhl Terkelsen, Claus Kjær Pedersen, Martin Kirk Christensen, Jens Flensted Lassen, Linda Hilsted, Søren Ladefoged, Mads Nybo, Morten Dahl, Pia Rørbæk Kamstrup, Henning Bundgaard, Christian Torp-Pedersen, Kasper Karmark Iversen
Zitieren
APA
Strandkjær, N., Jørgensen, N., Hasselbalch, R. B., Kristensen, J., Knudsen, M. S. S., Kock, T. O., Lange, T., Lindholm, M. G., Bruun, N. E., Holmvang, L., Terkelsen, C. J., Pedersen, C. K., Christensen, M. K., Lassen, J. F., Hilsted, L., Ladefoged, S., Nybo, M., Bor, M. V., Dahl, M., …, & Iversen, K. K. (2024). DANSPOT: A Multicenter Stepped‐Wedge Cluster‐Randomized Trial of the Reclassification of Acute Myocardial Infarction: Rationale and Study Design. Journal of the American Heart Association, 13(9). https://doi.org/10.1161/jaha.123.033493
Vancouver
Strandkjær N, Jørgensen N, Hasselbalch RB, Kristensen J, Knudsen MSS, Kock TO, et al. DANSPOT: A Multicenter Stepped‐Wedge Cluster‐Randomized Trial of the Reclassification of Acute Myocardial Infarction: Rationale and Study Design. Journal of the American Heart Association. 2024;13(9). doi:10.1161/jaha.123.033493
BibTeX
@article{Strandkjr2024,
author = {Strandkjær, Nina and Jørgensen, Nicoline and Hasselbalch, Rasmus Bo and Kristensen, Jonas and Knudsen, Marie Sophie Sander and Kock, Thilde Olivia and Lange, Theis and Lindholm, Matias Greve and Bruun, Niels Eske and Holmvang, Lene and Terkelsen, Christian Juhl and Pedersen, Claus Kjær and Christensen, Martin Kirk and Lassen, Jens Flensted and Hilsted, Linda and Ladefoged, Søren and Nybo, Mads and Bor, Mustafa Vakur and Dahl, Morten and Hansen, Annebirthe Bo and Kamstrup, Pia Rørbæk and Bundgaard, Henning and Torp-Pedersen, Christian and Iversen, Kasper Karmark},
title = {DANSPOT: A Multicenter Stepped‐Wedge Cluster‐Randomized Trial of the Reclassification of Acute Myocardial Infarction: Rationale and Study Design},
journal = {Journal of the American Heart Association},
year = {2024},
volume = {13},
number = {9},
doi = {10.1161/jaha.123.033493}
}
EUVIMED